By Elizabeth Troutman |
Newly introduced legislation would allow opioid, cocaine, methamphetamine, and alcohol to be eligible for an FDA breakthrough therapy designation in order to expedite the development and review of treatments.
U.S. Representative David Schweikert introduced the Substance Therapy Designation Act on April 1. The bill aims to ensure that the designation process for such treatments receives an even further fast-track.
“In the month of March alone, the United States Border Patrol has seized almost 15,000 pounds of controlled substances,” Schweikert said. “With the Substance Therapy Designation Act, I hope to be able to save more children that are falling victim to the continuing influx of these illicit drugs. This bill speaks to my continuing fixation of making our brothers and sisters healthier, while at the same time, promoting the safety and treatment from these addictive substances.”
Schweikert proposed the bill in response to Arizona’s increase in fentanyl coming across its border with Mexico illegally under the Biden administration’s border crisis. In the Nogales sector, Customs and Border Protection reported that it has seized over 8.5 million fentanyl pills since December 2023.
The total cost for opioid-related hospitalizations was $2.2 billion in 2022, a report from the Arizona Department of Health Services shows. Fentanyl is reportedly the most common component in many Arizona opioid overdoses. An average of three people die per day from fentanyl overdoses in Maricopa County.
Schweikert’s bill requires the Health and Human Services Secretary to grant priority review to substance abuse treatments and a fast-track designation to opioid, cocaine, methamphetamine, and alcohol treatments.
A number of treatments for substance abuse therapy are undergoing clinical trials. The first vaccine to combat cocaine addiction was formulated at the Federal University of Minas Gerais in Brazil.
A research team at the University of Houston plans to start manufacturing a clinical-grade vaccine that targets fentanyl after trials conducted with immunized rats succeeded. The vaccine blocks fentanyl from entering the brain.
Elizabeth Troutman is a reporter for AZ Free News. You can send her news tips using this link.
